MediciNova (MNOV) Institutional Ownership $1.38 -0.01 (-0.72%) Closing price 04:00 PM EasternExtended Trading$1.38 0.00 (0.00%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for MediciNova (NASDAQ:MNOV)CurrentInstitutional OwnershipPercentage9.90%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$391.10KNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$366.48K Get MNOV Insider Trade Alerts Want to know when executives and insiders are buying or selling MediciNova stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MNOV Institutional Buying and Selling by Quarter MediciNova Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2026 Dimensional Fund Advisors LP50,552$69K0.0%-22.2%0.103% 5/5/2026 Bank of New York Mellon Corp78,277$107K0.0%-18.6%0.159% 2/16/2026 Barclays PLC39,400$52K0.0%-55.5%0.080% 2/13/2026 State Street Corp193,698$254K0.0%+10.9%0.394% 2/12/2026 Jane Street Group LLC163,096$214K0.0%N/A0.332% 2/12/2026 StoneX Group Inc.19,200$25K0.0%N/A0.039% 2/10/2026 Goldman Sachs Group Inc.26,480$35K0.0%N/A0.054% 11/17/2025 Susquehanna International Group LLP122,879$155K0.0%-50.9%0.251% 11/17/2025 Citadel Advisors LLC72,897$92K0.0%N/A0.149% 8/15/2025 Bridgeway Capital Management LLC76,031$100K0.0%-24.7%0.000% Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 Bank of America Corp DE94,452$124K0.0%-27.3%0.000% 8/8/2025 SBI Securities Co. Ltd.43,479$57K0.0%-22.5%0.089% 2/17/2025Millennium Management LLC25,923$54K0.0%+26.7%0.053% 2/17/2025Bridgeway Capital Management LLC122,047$256K0.0%-15.9%0.249% 2/17/2025Bank of America Corp DE161,312$339K0.0%+111.3%0.329% 2/14/2025Jane Street Group LLC23,259$49K0.0%+64.5%0.047% 2/14/2025Schonfeld Strategic Advisors LLC35,751$75K0.0%-13.0%0.073% 2/13/2025Barclays PLC95,600$201K0.0%+15.5%0.195% 2/12/2025Geode Capital Management LLC514,914$1.08M0.0%+1.8%1.050% 2/6/2025SBI Securities Co. Ltd.53,771$113K0.0%N/A0.110% 2/4/2025Y Intercept Hong Kong Ltd36,957$78K0.0%N/A0.075% 11/16/2024Geode Capital Management LLC505,966$1.06M0.0%+10.3%1.032% 11/15/2024Jane Street Group LLC14,138$30K0.0%N/A0.029% 11/12/2024Charles Schwab Investment Management Inc.71,506$150K0.0%-47.0%0.146% 8/9/2024Renaissance Technologies LLC210,000$302K0.0%-8.9%0.428% 8/9/2024Dimensional Fund Advisors LP69,372$100K0.0%-35.6%0.141% 2/2/2024Bank Julius Baer & Co. Ltd Zurich19,000$28K0.0%N/A0.039% 12/6/2023Citigroup Inc.447,957$936K0.0%-10.1%0.913% 11/9/2023Citigroup Inc.447,957$936K0.0%-10.1%0.913% 11/7/2023Barclays PLC103,800$217K0.0%-7.7%0.212% 10/11/2023Capricorn Fund Managers Ltd30,459$64K0.0%N/A0.062% 8/10/2023Citigroup Inc.498,257$1.15M0.0%+11.2%1.016% 8/2/2023Bank of Montreal Can127,300$311K0.0%N/A0.260% 7/20/2023Bank Julius Baer & Co. Ltd Zurich18,650,237$42.90M0.0%+98,059.1%38.023% 4/18/2023Capricorn Fund Managers Ltd25,379$55K0.0%-62.0%0.052% 2/10/2023HRT Financial LP179,202$367K0.0%N/A0.365% 1/17/2023Capricorn Fund Managers Ltd66,716$137K0.0%N/A0.136% 11/3/2022Barclays PLC158,300$343K0.0%-12.6%0.323% 7/27/2022Bailard Inc.17,507$44K0.0%-38.0%0.036% 4/25/2022Bailard Inc.28,222$75K0.0%N/A0.058% Before you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listing2/14/2022Capricorn Fund Managers Ltd53,700$144K0.0%N/A0.109% 2/10/2022Qube Research & Technologies Ltd13,797$37K0.0%N/A0.028% MNOV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNOV shares? During the previous two years, 18 institutional investors and hedge funds held shares of MediciNova. The most heavily invested institutionals were Geode Capital Management LLC ($1.08M), Renaissance Technologies LLC ($302K), State Street Corp ($254K), Jane Street Group LLC ($214K), Susquehanna International Group LLP ($155K), Charles Schwab Investment Management Inc. ($150K), and Bank of America Corp DE ($124K).Learn more on MediciNova's institutional investors. What percentage of MediciNova's stock is owned by institutional investors? 9.90% of MediciNova's stock is owned by institutional investors. Learn more on MNOV's institutional investor holdings. Which institutional investors have been buying MediciNova's stock? Of the 11 institutional investors that purchased MediciNova's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jane Street Group LLC ($186.36K), Bank of America Corp DE ($84.96K), Citadel Advisors LLC ($72.90K), Geode Capital Management LLC ($56.15K), SBI Securities Co. Ltd. ($53.77K), Y Intercept Hong Kong Ltd ($36.96K), and Goldman Sachs Group Inc. ($26.48K). How much institutional buying is happening at MediciNova? Institutional investors have bought a total of 300,773 shares in the last 24 months. This purchase volume represents approximately $391.10K in transactions. Which of MediciNova's major shareholders have been selling company stock? The following institutional investors have sold MediciNova stock in the last 24 months: Susquehanna International Group LLP ($127.46K), Barclays PLC ($49.22K), Bank of America Corp DE ($35.53K), Bridgeway Capital Management LLC ($25K), Bank of New York Mellon Corp ($17.90K), Dimensional Fund Advisors LP ($14.46K), and SBI Securities Co. Ltd. ($12.60K). How much institutional selling is happening at MediciNova? Institutional investors have sold a total of 282,167 shares in the last 24 months. This volume of shares sold represents approximately $366.48K in transactions. Related Companies TRDA Institutional Ownership CGEN Institutional Ownership IKT Institutional Ownership HELP Institutional Ownership NERV Institutional Ownership ARTV Institutional Ownership FHTX Institutional Ownership FATE Institutional Ownership RNAC Institutional Ownership SGMT Institutional Ownership This page (NASDAQ:MNOV) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediciNova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediciNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
